Table 1.
Association between lncRNA-HGBC expression and clinicopathologic characteristics of GBC patients in the study cohort
| Characteristics | Cases | LncRNA-HGBC expression | χ2 value | P value | |
|---|---|---|---|---|---|
| Low (%) | High (%) | ||||
| Sex | 0.297 | 0.585 | |||
| Male | 14 | 6 (28.6%) | 8 (36.4%) | ||
| Female | 29 | 15 (71.4%) | 14 (63.6%) | ||
| Age (years) | 0.009 | 0.924 | |||
| < 60 | 12 | 6 (28.6%) | 6 (27.3%) | ||
| ≥ 60 | 31 | 15 (71.4%) | 16 (72.7%) | ||
| Histology differentiation | 0.007 | 0.933 | |||
| Well or moderate | 33 | 16 (76.2%) | 17 (77.3%) | ||
| Poor | 10 | 5 (23.8%) | 5 (22.7%) | ||
| TNM stage (AJCC) | 6.702 | 0.0096 | |||
| 0-II | 20 | 14 (66.7%) | 6 (27.3%) | ||
| III-IV | 23 | 7 (33.3%) | 16 (72.7%) | ||
| Lymph node Metastasis | 5.495 | 0.0191 | |||
| Present | 18 | 5 (23.8%) | 13 (59.1%) | ||
| Absent | 25 | 16 (76.2%) | 9 (40.9%) | ||
AJCC American Joint Committee on Cancer, Bold type indicates statistical significance